The American vaccine company Moderna claims that the full results of their research suggest that the vaccine is 94.1 percent effective against corona. The agency claims that the vaccine works 100 percent on high-risk patients. “We believe that we have developed a vaccine that works very well,” said Tal Jack, Modern’s chief medical officer. We have evidence to support this. The vaccine is set to play a major role in preventing the spread of the disease.
A statement from the Moderna agency said, “Modern has applied to the US Food and Drug Administration (FDA) for an emergency clearance of the vaccine. The European Medicines Agency has also been asked to allow the vaccine to be legalized in various European countries.
“It’s a great event,” said Alexander Edward, a professor of biomedical technology at the University of Reading. The more testing information we get, the richer our research against Covid-19 is. Also, we will be confident in the battle to defeat Covid-19. When the vaccine comes on the market, the public will also believe that the vaccine has come to fight their epilepsy.
Pfizer also recently applied for the same approval. Pfizer’s data has reached European companies. They are reviewing it. The ticker data from AstraZeneca and Oxford are also being investigated. Moderna says it will soon get approval from Europe. The data was tested on 30,000 volunteers. According to one source, the vaccine is 100 percent effective on high-risk patients.
However, part of the Expert i.e (informed community) thinks that if the Moderna vaccine comes on the market, it will cost more than AstraZeneca or Pfizer. His view is that the vaccine may be relatively less effective than Pfizer or Moderna.
That is, all the preparation phase. Now just waiting for Vaccine approval from .